With Lilly on board, Entos’ medical chief champions genetic platform with ‘unlimited’ potential

Listen to the article 6 min This audio is auto-generated. Please let us know if you have feedback. Entos Pharmaceuticals is on the verge of “leveling up,” and Steve Chen is excited to help them get there. “I think the company right now is actually going through what I would call a major inflection point,” … Read more

Medical regulator faces questions over board members’ links to drug firms | NHS

The UK medicines watchdog has been urged to strengthen its conflict of interest policy after it emerged that six of its board members are receiving payments from the pharmaceutical industry. Board members involved in overseeing the regulator’s “strategic direction” also have financial interests in companies including US and Saudi drug giants and firms with ambitions … Read more